Treating the opioid epidemic has challenged researchers and providers for years. Looking at patient adherence — both to opioid substitutes and painkillers — has been an avenue several companies have begun to look at.
Recently Toronto-based nGageIT has unveiled its latest digital health product, NanoSmart, which can use a patient’s breath to determine their medication adherence. The platform...
